Related Experiment Video
Updated: Jul 11, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Modeling and acquisition of drug-drug interaction knowledge
Frédéric Mille1, Patrice Degoulet, Marie-Christine Jaulent
1INSERM, UMR S 872, Eq 20, Les Cordeliers, Paris, F-75006 France. frederic.mille@rdb.aphp.fr
Objectives:
The effectiveness of computerized clinical decision support systems (CDSS) depends on the quality of the knowledge they refer to. In this article, we are interested in the acquisition, modeling and representation of the knowledge embedded in the "national reference framework of drug-drug interaction" published by the French Health Products Safety Agency.
Methods:
A model of drug-drug interactions has been designed using bottom-up and top-down approaches. This model is the basis for the design of an XML format to represent and extract information on drug interactions from the reference framework.
Results:
A specific tool has been developed to extract the information from a corpus of 1053 drug monographs using a methodology similar to the one used by the GEM-Cutter tool to extract information from clinical guidelines. Strategies to integrate the XML files produced into CDDSSs are discussed.
Discussion-Conclusion:
Modeling and acquisition of drug-drug interaction knowledge from a corpus of drug monographs is a potential approach to foster the development of CDSS and improve their specificity.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Quantitative Aspects of Drug-Receptor Interaction
